Can schistosomiasis really be consigned to history without a vaccine?
Recently, considerable enthusiasm has been expressed for expanding and combining control efforts for neglected tropical diseases (NTDs). While these efforts are laudable, the drugs in question require repeated mass administration for indefinite periods of time, and their use to achieve eradication is fraught with challenges. Mass drug administration is unlikely to be effective in isolation, and should not proceed without concurrent control methods, such as vaccines. Schistosomiasis is one of the most important NTDs, and one whose effective control is unlikely in the absence of improved sanitation and a vaccine. Recent advances in biotechnologies have enhanced antigen discovery and new molecules that show promise as recombinant vaccines are being reported. Funding bodies supporting research into the control of schistosomiasis should invest not only in mass drug administration but also in the development of new control strategies, including the development of vaccines.
Jeffrey M
JM
Bethony
David J
DJ
Diemert
Sergio Costa
SC
Oliveira
Alex
A
Loukas
D000818:Animals; D000947:Antigens, Helminth / Q000235:genetics / Q000276:immunology*; D006801:Humans; D012547:Schistosoma / Q000235:genetics / Q000276:immunology*; D012552:Schistosomiasis / Q000517:prevention & control*; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology
D000947:Antigens, Helminth; D014614:Vaccines, Synthetic